Six IPOs and one direct listing debuted this week. Seven IPOs and two SPACs submitted initial filings.AI-focused cloud computing provider CoreWeave (CRWV) priced its downsized IPO well below the range to raise $1.5 billion at a $22.4 billion market cap. The...read more
NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, announced the effectiveness of its registration statement pursuant to a direct listing on the Nasdaq on March 26, 2025. The company registered 2.1 million...read more
Two small IPOs listed this week. Four IPOs and two SPACs submitted initial filings.Chinese industrial machinery producer INLIF (INLF) priced at the bottom of the range to raise $8 million at a $58 million market cap. The company develops, manufactures, and...read more
NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, filed on Friday to register its shares with the SEC and complete a direct listing on the Nasdaq. The shares of common stock listed will be sold by...read more
US IPO Weekly Recap: CoreWeave fails to impress in downsized IPO, as more names join the pipeline
Six IPOs and one direct listing debuted this week. Seven IPOs and two SPACs submitted initial filings.AI-focused cloud computing provider CoreWeave (CRWV) priced its downsized IPO well below the range to raise $1.5 billion at a $22.4 billion market cap. The...read more
Biotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing
NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, announced the effectiveness of its registration statement pursuant to a direct listing on the Nasdaq on March 26, 2025. The company registered 2.1 million...read more
US IPO Weekly Recap: 2 microcaps list as more small issuers file for listings
Two small IPOs listed this week. Four IPOs and two SPACs submitted initial filings.Chinese industrial machinery producer INLIF (INLF) priced at the bottom of the range to raise $8 million at a $58 million market cap. The company develops, manufactures, and...read more
Brain cancer biotech NeOnc Technologies files for a Nasdaq direct listing
NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, filed on Friday to register its shares with the SEC and complete a direct listing on the Nasdaq. The shares of common stock listed will be sold by...read more